151 related articles for article (PubMed ID: 29725469)
1. Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma.
Xu X; Li P; Fu D; Wei Z; Xu S; Xu F; Tian F; Ge J; Zhang Z; Cheng W
Oncol Lett; 2018 May; 15(5):7739-7743. PubMed ID: 29725469
[TBL] [Abstract][Full Text] [Related]
2. Moesin (
Park JH; Lee C; Han D; Lee JS; Lee KM; Song MJ; Kim K; Lee H; Moon KC; Kim Y; Jung M; Moon JH; Lee H; Ryu HS
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32326232
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.
Fu L; Zhang J; Li L; Yang Y; Yuan Y
Oncol Lett; 2020 Feb; 19(2):1165-1174. PubMed ID: 31966046
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
[TBL] [Abstract][Full Text] [Related]
5. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of BTA, NMP22, survivin and cytology in urothelial carcinoma.
Gong YW; Wang YR; Fan GR; Niu Q; Zhao YL; Wang H; Svatek R; Rodriguez R; Wang ZP
Transl Cancer Res; 2021 Jul; 10(7):3192-3205. PubMed ID: 35116626
[TBL] [Abstract][Full Text] [Related]
7. Value of urinary survivin as a diagnostic marker in bladder cancer.
Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
[TBL] [Abstract][Full Text] [Related]
8. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer.
Eissa S; Shabayek MI; Ismail MF; El-Allawy RM; Hamdy MA
IUBMB Life; 2010 May; 62(5):394-9. PubMed ID: 20408180
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluorescence in situ hybridization, NMP22 bladderchek, and urinary liquid-based cytology in the detection of bladder urothelial carcinoma.
Li HX; Wang MR; Zhao H; Cao J; Li CL; Pan QJ
Diagn Cytopathol; 2013 Oct; 41(10):852-7. PubMed ID: 23444210
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Urine Cytology in Urothelial Carcinoma Patients: A Comparison of CellprepPlus® Liquid-Based Cytology and Conventional Smear.
Son SM; Koo JH; Choi SY; Lee HC; Lee YM; Song HG; Hwang HK; Han HS; Yun SJ; Kim WJ; Kim EJ; Lee OJ
Korean J Pathol; 2012 Feb; 46(1):68-74. PubMed ID: 23109981
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine.
Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M
Cytopathology; 2019 Sep; 30(5):510-518. PubMed ID: 30943322
[TBL] [Abstract][Full Text] [Related]
13. [Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer].
Jiang LL; Xie MM; Wang XR; Zhao Y; Wang ZJ
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3520-2. PubMed ID: 24521893
[TBL] [Abstract][Full Text] [Related]
14. Direct Smear Versus Liquid-Based Cytology in the Diagnosis of Bladder Lesions.
Kalantari MR; Jahanshahi MA; Gharib M; Hashemi S; Kalantari S
Iran J Pathol; 2022; 17(1):56-64. PubMed ID: 35096089
[TBL] [Abstract][Full Text] [Related]
15. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
Shariat SF; Casella R; Khoddami SM; Hernandez G; Sulser T; Gasser TC; Lerner SP
J Urol; 2004 Feb; 171(2 Pt 1):626-30. PubMed ID: 14713774
[TBL] [Abstract][Full Text] [Related]
16. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of malignancy for non-atypical urothelial cell groups compared to negative cytology in voided urine. Morphological changes with LBC.
Granados R; Butrón M; Santonja C; Rodríguez JM; Martín A; Duarte J; Camarmo E; Corrales T; Aramburu JA
Diagn Cytopathol; 2016 Jul; 44(7):582-90. PubMed ID: 27089849
[TBL] [Abstract][Full Text] [Related]
18. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
20. Is liquid-based cytology an alternative to conventional cytology for detection of malignant cells in urine of bladder cancer? Eastern Indian prospective observational study.
Kapoor K; Datta C; Pal DK
Turk J Urol; 2019 Sep; 45(5):351-356. PubMed ID: 31509507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
